FNY Investment Advisers, LLC
Position in CERO — Cero Therapeutics Holdings, Inc.
CIK 1742998
NEW YORK, NY
Position in CERO
as of Sep 30, 2025
· filed Dec 15, 2025
Position Value
$5,344
-$4,767 QoQ
Shares Held
1,050
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 11 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FNY Investment Advisers, LLC holds $19,945,542 across 57 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 108,951 | $13,455,448 | |||
| 2 | ABVX |
Abivax S.A.
|
7,605 | $1,013,442 | |
| 3 | SGMT |
Sagimet Biosciences Inc.
|
109,250 | $844,502 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
5,000 | $663,650 | |
| 5 | JANX |
Janux Therapeutics, Inc.
|
30,850 | $473,856 | |
| 6 | NKTR |
Nektar Therapeutics
|
5,500 | $383,955 | |
| 7 | VERU |
Veru Inc.
|
105,081 | $328,903 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
8,170 | $318,711 |
All Filings in CERO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-09-30 | $5,344 | 1,050 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $10,111 | 1,050 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $191 | 262 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $157 | 26,250 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2 | 26,250 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1 | 5,250 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $32,235 | 10,500 | Shares | Sole | 2024-05-03 | |
| 2023-06-30 | $22,715 | 2,084 | Shares | Sole | 2023-07-11 | |
| No filing history on record for this holder in this stock. | ||||||